He-Yueya, Joy http://orcid.org/0000-0002-1831-7415
Buck, Benjamin
Campbell, Andrew
Choudhury, Tanzeem
Kane, John M.
Ben-Zeev, Dror
Althoff, Tim
Article History
Received: 4 June 2020
Accepted: 9 October 2020
First Online: 23 November 2020
Competing interests
: T.C. is a co-founder and holds equity stake at HealthRhythms Inc. J.M.K. has been a consultant to or received honoraria for lectures from Allergen, Alkermes, Intracellular Therapies, Janssen, LB Pharma, Lundbeck, Merck, Minerva, Neurocrine, Newron, Otsuka, Roche, Sunovion, Sumitomo Dainippon, Teva. He is a shareholder in LB Pharma and The Vangurad Research Group. D.B.-Z. has an intervention content licensing agreement with Pear Therapeutics and has a financial interest in FOCUS smartphone technology and in Trusst Health, Inc. He has provided consultation to eQuility and Otsuka. The other authors declare no competing interests.